Two randomized trials of linaclotide for chronic constipation.
about
Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised EditionIrritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentRecent Updates on the Treatment of ConstipationAbdominal bloating: pathophysiology and treatmentLinaclotide: a new option for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation in adultsMeasuring response in the gastrointestinal tract in systemic sclerosisTreatment for constipation: new and old pharmacological strategiesNovel therapies for constipationGUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrityElobixibat and its potential role in chronic idiopathic constipationPersistent constipation and abdominal adverse events with newer treatments for constipation.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Sildenafil normalizes bowel transit in preclinical models of constipationUnderstanding and treating refractory constipation.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipationLuminally Acting Agents for Constipation Treatment: A Review Based on Literatures and Patents.Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Effects of lubiprostone on pacemaker activity of interstitial cells of cajal from the mouse colon.Impact of linaclotide treatment on work productivity and activity impairment in adults with irritable bowel syndrome with constipation: results from 2 randomized, double-blind, placebo-controlled phase 3 trials.Chronic constipation in the elderly.Psychometric validation of patient-reported outcome measures assessing chronic constipation.Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.American Gastroenterological Association technical review on constipation.Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.The paracrine hormone for the GUCY2C tumor suppressor, guanylin, is universally lost in colorectal cancerCurrent and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.The impact of abdominal pain on global measures in patients with chronic idiopathic constipation, before and after treatment with linaclotide: a pooled analysis of two randomised, double-blind, placebo-controlled, phase 3 trialsLarazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.Linaclotide in Chronic Idiopathic Constipation Patients with Moderate to Severe Abdominal Bloating: A Randomized, Controlled TrialAdvancing treatment options for chronic idiopathic constipation.Medical management of constipation.Chronic constipation: new diagnostic and treatment approachesLinaclotide: evidence for its potential use in irritable bowel syndrome and chronic constipation.Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis.A 12-week, randomized, controlled trial with a 4-week randomized withdrawal period to evaluate the efficacy and safety of linaclotide in irritable bowel syndrome with constipationEffective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Randomised controlled trial of mesalazine in IBS.Linaclotide (Linzess) for Irritable Bowel syndrome With Constipation and For Chronic Idiopathic Constipation
P2860
Q26745952-8D50FDEE-2690-4972-B19A-0DD636C8B6ABQ26751193-D1F91D5F-C09E-45B9-B0E3-025EBE2579EDQ26820242-8A4542EF-9309-42FD-936E-F428434E202AQ26851622-F15D2E6F-B713-4379-B859-0CBA7E4BFD08Q27010449-1FA6DEAB-5234-467F-9268-6A9A8DB9E7F8Q27022416-9B667647-90F7-4BAF-AFDF-F578AA16B00AQ27027346-10CB72A7-2E80-4897-B13D-38089FB4206FQ27027873-ED745B06-A756-4A32-B5EB-AD11C9E3CAF9Q27308895-4988E75B-30EB-4500-8E70-B942BEBFC6A2Q28244603-B4DDB9D9-EFD7-453C-96F2-D80CDF2CEC8FQ33468562-5B5E113D-30E8-4FB7-9537-788BA2DA1F29Q33586854-C84FCF17-4BE3-4C6E-9A9C-A80AFF42D5B0Q33610799-451D9CED-F100-4033-A0CA-95534AB7CDBDQ33621273-8CF2869C-3786-4C23-A54C-498D9544C265Q33695487-3DF0C2D4-4FE2-4A55-A59A-751E60675E4EQ33854983-71BB135D-6C24-461B-8025-4CDDEBC2945BQ33958710-326016E4-8F2C-49AF-BDC7-781D01C1EE57Q34097910-ACF4FAD1-3038-4556-9D8E-6CFFA521B2EBQ34179472-75D12B69-50FD-4079-9BEF-6262A61D39ADQ34223161-1FA2F83E-5689-4128-99A4-F0DFCD83C5D2Q34293147-838048D4-1DB9-4DF5-8586-AA621FB8F41CQ34309302-959A7359-DAA4-43A3-B404-403D26D7B42DQ34319119-ACDB8613-650C-4FB0-AD27-DABABE5479DBQ34323319-048D57BB-5A9B-4899-AE2F-4477699E8B28Q34392861-0E2ED871-035D-44A4-A76F-1830B71E055CQ34458591-99A66F28-CCDC-4E1F-AD66-72329C1A87FBQ34478089-1902ACB9-20C2-40CA-8F67-518B392C15B1Q34522966-664287F2-E969-4570-B07A-B89F7BC8B65AQ34782198-1E21343B-CE59-4BEC-9070-82FE5E94DC22Q35655989-7A8EB147-59AA-47A6-A756-1D6553186413Q35723125-21F5398D-C6A5-4418-A659-637C7D09F32FQ35858864-7C890E54-B983-4390-BBB2-F8DC52E67D23Q35948228-133D78ED-5CF2-4CA2-BCC4-6D9BD1EC776AQ36072686-D8B69FA6-2491-4904-87E2-ED32D0A0C70DQ36092886-CD7053B9-3B77-416A-9FA9-34C57B7179B0Q36096138-2880CCA6-047E-4965-AA19-B7EC803698FDQ36417684-E742EFAB-6D6A-4920-83CD-20F6F827DAB1Q36426025-16CF46DC-7070-4D06-80FE-78F95EF48A46Q36475502-5C2B391E-F09C-4BB8-923A-46AD771FCF9FQ36801233-77870B86-8AE5-4287-8FF6-771018749103
P2860
Two randomized trials of linaclotide for chronic constipation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Two randomized trials of linaclotide for chronic constipation.
@en
Two randomized trials of linaclotide for chronic constipation.
@nl
type
label
Two randomized trials of linaclotide for chronic constipation.
@en
Two randomized trials of linaclotide for chronic constipation.
@nl
prefLabel
Two randomized trials of linaclotide for chronic constipation.
@en
Two randomized trials of linaclotide for chronic constipation.
@nl
P2093
P356
P1476
Two randomized trials of linaclotide for chronic constipation.
@en
P2093
Anthony J Lembo
Bernard J Lavins
Brenda I Jeglinski
Caroline B Kurtz
Donald A Fitch
Harvey A Schneier
James E MacDougall
James Z Shao
Jeffrey M Johnston
Mark G Currie
P304
P356
10.1056/NEJMOA1010863
P407
P577
2011-08-01T00:00:00Z